Cargando…
SupplAzithromycin for Prevention of Graft-Versus-Host Disease: A Randomized Placebo-Controlled Trial
Background: Allogeneic hematopoietic stem cell transplantation has been used widely to treat various types of malignant and non-malignant disorders. Graft-versus-host disease is one of the main complications of this procedure which is associated with considerable mortality and affects quality of lif...
Autores principales: | Barkhordar, Maryam, Mohammadi, Mehdi, Hadjibabaie, Molouk, Ghavamzadeh, Ardeshir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141429/ https://www.ncbi.nlm.nih.gov/pubmed/30233767 |
Ejemplares similares
-
Effects of short-term pretreatment with atorvastatin on mobilization of hematopoietic progenitor cells: A double-blind, randomized, controlled trial
por: Mohammadi, Mehdi, et al.
Publicado: (2015) -
Assessment of Cyclosporine Serum Concentrations on the Incidence of Acute Graft Versus Host Disease Post Hematopoietic Stem Cell Transplantation
por: Zeighami, Sara, et al.
Publicado: (2014) -
Impact of CYP2C19 Polymorphisms on Serum Concentration of Voriconazole in Iranian Hematological Patients
por: Ebrahimpour, Sholeh, et al.
Publicado: (2017) -
Evaluation of the Interaction of Intravenous and Oral Voriconazole with Oral Cyclosporine in Iranian HSCT Patients
por: Masoumi, Hamidreza Taghvaye, et al.
Publicado: (2017) -
Selenium supplementation in patients undergoing hematopoietic stem cell transplantation: effects on pro-inflammatory cytokines levels
por: Daeian, Nesa, et al.
Publicado: (2014)